ISOLF — Isodiol International Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Isodiol International, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.

	2015 March 31st	2016 March 31st	2017 March 31st	2018 March 31st	2019 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0	0.017	0.356	19.1	22.2
Cost of Revenue
Gross Profit	0	0.01	0.127	8.88	7.38
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	0.913	8.62	4.56	54.2	129
Operating Profit	-0.913	-8.6	-4.2	-35.1	-106
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.913	-8.68	-4.29	-35.7	-121
Provision for Income Taxes
Net Income After Taxes	-0.913	-8.68	-4.29	-36	-121
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-0.913	-8.68	-4.29	-36	-126
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-0.913	-8.68	-4.29	-36	-126
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-3.96	-1.72	-1.11	-1.34	-1.88
Dividends per Share